Since miR-651-5p expression was higher in EGFR-mutant cell lines than wild type cell lines, the EGFR-TKI and epidermal growth factor (EGF) were used to treat NSCLC cell lines to explore whether it was regulated by the EGFR signaling pathway (Figure 4a). The gene discussed is EGF; the disease is non-small cell lung carcinoma.